SMTL ID : 3qql.1

CDK2 in complex with inhibitor L3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x X03: (5R)-5-(2-methylbutan-2-yl)-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide(Non-covalent)

X03.1: 15 residues within 4Å: Chain A: I.18, V.26, A.39, K.41, F.88, E.89, F.90, L.91, H.92, Q.93, Q.139, N.140, L.142, A.152, D.153 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.26, A:F.88, A:N.140, A:A.152 Hydrogen bonds: A:E.89, A:L.91, A:L.91, A:H.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schonbrunn, E. et al., Structure-guided optimization of novel CDK2 inhibitors discovered by high-throughput screening. To be Published

Release Date

2012-08-08

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence